Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS smartwatches. That’s pretty inside baseball for the wearable industry, but it takes an interesting turn when you realize Masimo is also the reason why the new Apple Watch Series 10 doesn’t have blood oxygen features in the US.

Google, Masimo, and Qualcomm are working together to boost health tracking on Wear OS with new, premium features. Google’s new partnership means it has licensed Masimo’s blood oxygen tech, plus other health features.

Google has now partnered with Masimo and Qualcomm to create health-focused Wear OS reference platforms, integrating Masimo's advanced medical sensors and Qualcomm's Snapdragon chipsets.

Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health tracking.

Masimo has signed a deal with Google to bring a new hardware platform for smartwatch manufacturers, which could create a hardware influx of Wear OS-powered devices.

Masimo has announced collaboration with Google and Qualcomm to build a smartwatch reference platform for OEMs to use. Read on to know more!

Masimo (MASI) partners with Google (GOOG) to develop a new reference platform for original equipment manufacturers

Google has announced a partnership with Masimo to build a reference platform for OEMs to use for health and fitness when developing Wear OS watches.